Efficacy and comparison of Shatapushpa Taila Matrabasti with Shatapushpa Churna in Kashtartava (Dysmenorrhoea)
Kashtartava (dysmenorrhoea) affects women’s day to day activity and it is most common complaints amongst adolescents. 75% of adolescents experience pain during menstruation. Dysmenorrhoea can also be associated with nausea, vomiting, diarrhoea, fatigue, blotting abdomen etc. As per Ayurveda Apanavata is the governing force of menstruation; its vitiation gives rise to many gynaecological diseases ( yonivyapad). Kashyapa has mentioned Shatapushpa (Anethum sowa Kurz.) as drug of choice for Artava related problems. So that group A is treated with Shatapushpa churana and group B with Shatapushpa taila matra basti. Shatapushpa Churna and Shatapushpa taila matrabasti showed extremely significant (P< 0.0001) relief in severity of pain however showed significant relief in duration of Pain, Nausea and Breast Tenderness. Overall effect of treatment on Group A showed complete remission 27.27% whereas Group B showed 63.64%. Statistically both groups are expressed significant results, whereas on the basis of clinical symptoms and overall effect of treatment illustrated in the study the Shatapushpa taila matrabasti is more effective than Shatapushpa churna.
Copyright (c) 2021 International Journal of Ayurvedic Medicine
This work is licensed under a Creative Commons Attribution 4.0 International License.
The author hereby transfers, assigns, or conveys all copyright ownership to the International Journal of Ayurvedic Medicine (IJAM). By this transfer, the article becomes the property of the IJAM and may not be published elsewhere without written permission from the IJAM.
This transfer of copyright also implies transfer of rights for printed, electronic, microfilm, and facsimile publication. No royalty or other monetary compensation will be received for transferring the copyright of the article to the IJAM.
The IJAM, in turn, grants each author the right to republish the article in any book for which he or she is the author or editor, without paying royalties to the IJAM, subject to the express conditions that (a) the author notify IJAM in advance in writing of this republication and (b) a credit line attributes the original publication to IJAM.